WINT

Windtree Therapeutics
WINT

Overview Fund Activity
Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

19 hedge funds and large institutions have $3.02M invested in Windtree Therapeutics in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 11 closing their positions.

Holders
19
Holders Change
-8
Holders Change %
-29.63%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
3
Closed
11
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$1K

Top Buyers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$327K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.38M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$386K
4
Skandinaviska Enskilda Banken (SEB)
4
Skandinaviska Enskilda Banken (SEB)
Sweden
$228K
5
Northern Trust
5
Northern Trust
Illinois
$148K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
PAM
2
PVG Asset Management
Colorado
$0
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
FWM
4
Frontier Wealth Management
Missouri
$0
5
Envestnet Asset Management
5
Envestnet Asset Management
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TSS
26
Two Sigma Securities
New York
– – -10,139 Closed
ASN
27
Advisory Services Network
Georgia
– – -2,000 Closed
PA
28
Parallel Advisors
California
$0 11 – –
GI
29
Gradient Investments
Minnesota
$0 23 – –
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
Morgan Stanley
31
Morgan Stanley
New York
$0 25 +25 New
1
2